In 2025, venture capital investment in the healthcare sector for artificial intelligence-related deals set a new record, exceeding US$300 million.
This global trend of surging interest in the health tech sector is increasingly being reflected in Latin America, where trailblazing startups are driving innovation.
One example is metaBIX Biotech, a Uruguayan startup that recently took a bold step toward its expansion across Latin America thanks to a fresh funding round of US$1.3 million. With this capital injection, the startup will focus on growing in Brazil, a key market for healthcare innovation.
Recently, the Brazilian government announced plans to incorporate technology to streamline and improve the accuracy of rare disease diagnosis. The Ministry of Health estimates that at least 13 million people in the country suffer from rare diseases.
Technology is key to reducing diagnosis time to improve treatment and patients’ quality of life, while also enabling the launch of new services to treat rare diseases.
metaBIX Biotech uses artificial intelligence to anticipate diseases before they become a major problem. By using AI and biotechnology to analyze data and provide predictions, it aims to change the way people manage their health.
“We are moving from validating the technology to expanding its impact globally. Brazil will be our main market by 2026, as we strengthen our strategic partnerships in major economies,” said Laura Macció, co-founder and CEO of the startup.
Brazil as a key market
Investors believe that metaBIX Biotech presents a solid offer within the healthtech sector, as its technology is not only innovative but also addresses a real need: making healthcare systems more efficient.
The firm identified Brazil as the ideal country to target for growth, given its size, dynamism, and openness to new technological solutions in the medical field.
Beyond expansion, the project has a deeply human focus, as the technology developed by the startup aims to directly impact people’s lives by helping detect risks early and enabling more informed decisions.
The heart of the company lies in its ability to combine science and data, as its technology transforms complex information into useful tools for healthcare professionals, facilitating more accurate and timely diagnoses.
Industry growth
The fastest-growing areas in HealthTech are telemedicine, artificial intelligence in clinical settings, digital mental health, and remote patient monitoring, according to the panel discussion “Public Health in Medellín,” held in late 2025. Overall, 14% growth is projected for 2032, according to Lina Morales, director of Colombia HealthTech.
In Medellin, companies such as 360 Health Data—a platform created by Colombian technology experts to overcome healthcare inequalities caused by language barriers—are making strides.
Its platform, Coralia Health, translates medical knowledge and resources into Spanish using technology-based automation, meaning that doctors in the region now have quick access to up-to-date, reliable, and relevant information.
HealthTech investments in Latin America grew by 36.6% in 2024 to reach US$253.3 million, reflecting the region’s commitment to technological solutions that improve patient health.
The health panel also highlighted that Brazil and Mexico lead the market, followed by Colombia, Chile, and Argentina, which are emerging as new hubs and candidates for expansion.
The future and new players
A new generation of women entrepreneurs in the healthcare sector is working to reduce the biases that exist in the medical world, particularly regarding medications and devices currently on the market that are often suboptimal for women.
One example is Ourself Health, Adriana Torosian’s feminine health platform, focused on helping women understand how hormones influence their daily wellbeing.
This week, the company announced the launch of Stella, an AI-powered health app designed to help women connect the dots between hormones, symptoms, and daily patterns, and turn that knowledge into personalized guidance and actions.
“Our goal has always been to help women understand what’s happening in their bodies and why,” said Adriana Torosian, founder of Ourself Health.
The arrival of new startups and the expansion of others not only validate venture capital’s interest in the region but also confirm that using science and data to achieve more efficient healthcare systems, more accurate diagnoses, and more equitable care—including combating historical biases in medicine—is a viable path forward.
As areas such as telemedicine and digital mental health continue to grow, and with new hubs emerging in Colombia, Chile, and Argentina, Latin America is establishing itself as a key driver of high-impact medical innovation in the years to come.
